The ALLHAT study: If you believe in evidence-based medicine, stick to it!

Journal of Hypertension

Volumn 21, Issue 3, 2003, Pages 453-454

  Julius, Stevo ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; EDITORIAL; EVIDENCE BASED MEDICINE; HIGH RISK PATIENT; HYPERTENSION; PRIORITY JOURNAL;

EID: 0037357939     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200303000-00001     Document Type: Editorial

References (13)

1. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
2. Neaton JD, Kuller L, Stamler J, Wentworth DN. Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: Editor A, Editor B (editors): Hypertension: Pathophysiology, Diagnosis and Management, 2nd edn. Location: Publisher; 1995, pp. 99-114.
3. Anonymous. The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet 1980; 1:1261-1267.
4. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317:713-720.
5. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al., for the HOT Study Group. Effects of intensive bleed-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762.
6. Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al., for the LIFE study group. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359:1004-1010.
7. Kjeldsen SE, Dahlof B, Devereux RB, Julius S, Aurup P, Edelman J, et al., for the LIFE study group. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A Losartan Intervention For Endpoint Reduction (LIFE) Substudy. JAMA 2002; 288:1491-1498.
8. Hansson L, Lindholm LH, for the STOP-Hypertension-2 study group. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354:1751-1756.
9. Hansson L, Hedner T, for the NORDIL Study Group. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000; 356:359-365.
10. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356:366-372.
11. Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K. The association of borderline hypertension with target organ changes and higher coronary risk: Tecumseh Blood Pressure Study. JAMA 1990; 264:354-358.
12. Berne C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care 1991; 14(suppl 4):39-47.
13. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al., for the Captopril Prevention Project (CAPPP) study group. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999; 353:611-616.